Practical advice for Early Scientific Advice (ESA) in HTA submissions
pharmaphorum
SEPTEMBER 28, 2022
In recent years, the biopharma market has become progressively complex. As a result, payers are feeling increased pressure to make the right decisions based on the perceived value of each product. HTA agencies can assist biopharma companies at the early stages of development to ensure they are meeting the expectations of payers.
52 
Let's personalize your content